Influence of Enteric‐Coated Lactose on the Release Profile of 4‐Aminopyridine from HPMC Matrix Tablets

References

• Masterson J. G., Myers M. Formulations and Their Use in the Treatment of Neurological Diseases. US patent 5,580,580, 1996
   Google Scholar
• Hanseabout R. R., Blight A. R. Use of 4‐Aminopyridine in the Reduction of Chronic Pain and Spasticity in Spinal Cord Injured Patients. US patent 5,545,648, 1996
   Google Scholar
• Kibbe A. H. Handbook of Pharmaceutical Excipients3rd Ed. The Pharmaceutical Press, London and The American Pharmaceutical Association, Washington, DC 2000; 252–255
   Google Scholar
• Mandal T. K. The influence of binding solvents on drug release from hydroxypropyl methylcellulose tablets. Drug Dev. Ind. Pharm. 1995; 21: 1389–1397
   Web of Science ®Google Scholar
• Higuchi T. Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 1963; 52(12)1145–1149
   PubMed Web of Science ®Google Scholar
• Efentakis M., Vlachou M., Choulis N. H. Effects of excipients on swelling and drug release from compressed matrices. Drug Dev. Ind. Pharm. 1997; 23: 107–112
   Web of Science ®Google Scholar
• Martini A., Montagno Cappuccinello M., Artico R., Muggetti L., De Ponti R. Hydrophilic matrices as controlled‐release formulations for a 5α‐reductase inhibitor. Pharm. Sci. 1995; 1: 555–558
   Google Scholar
• Campos‐Aldrete M. E., Villafuerte‐Robles L. Sistema metronidazol‐hidroxipropilmetilcelulosa de liberación prolongada I. Efecto de la carga del fármaco. Rev. Mex. Cienc. Farm. 1991; 22: 83–93
   Google Scholar
• Campos‐Aldrete M. E., Villafuerte‐Robles L. Influence of viscosity grade and the particle size of HPMC on metronidazole release from matrix tablets. Eur. J. Pharm. Biopharm. 1997; 43: 173–178
   Web of Science ®Google Scholar
• Mitchell K., Ford J. L., Armstrong D. J., Elliot P. N.C., Hogan J. E., Rostron C. The influence of the particle size of hydroxypropylmethylcellulose K15M on its hydration and performance in matrix tablets. Int. J. Pharm. 1993; 100: 175–179
   Web of Science ®Google Scholar
• Kim H., Fassihi R. Application of binary polymer system in drug release modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics. J. Pharm. Sci. 1997; 86: 323–328
   PubMed Web of Science ®Google Scholar
• Vázquez M. J., Pérez‐Marcos B., Gómez‐Amoza J. L., Martínez‐Pacheco R., Souto C., Concheiro A. Influence of technological variables on release of drugs from hydrophilic matrices. Drug Dev. Ind. Pharm. 1992; 18: 1355–1375
   Web of Science ®Google Scholar
• Traconis N., Rodríguez R., Campos M. E., Villafuerte L. Influence of admixed polymers on the metronidazole release from hydroxypropyl methylcellulose matrix tablets. Pharm. Acta Helv. 1997; 72: 131–138
   Google Scholar
• Lapidus H., Lordi N. J. Drug release from compressed hydrophilic matrices. J. Pharm. Sci. 1968; 57: 1292–1301
   PubMed Web of Science ®Google Scholar
• Holgado M. A., Caraballo I., Alvarez‐Fuentes J., Fernández‐Hervás M. J., Fernández‐Arévalo M., Rabasco A. M. Influence of diluents and manufacturing method on the in vitro dissolution of carteolol hydrochloride matrix tablets. Int. J. Pharm. 1995; 118: 151–160
   Web of Science ®Google Scholar
• Espinoza R., Villafuerte L. Influence of admixed lactose on pelanserin hydrochloride release from hydroxypropyl methylcellulose matrix tablets. Pharm. Acta Helv. 1999; 74: 65–71
   Google Scholar
• Veiga F., Salsa T., Pina M. E. Influence of technological variables on the release of theophylline from hydrophilic matrix tablets. Drug Dev. Ind. Pharm. 1997; 23: 547–551
   Web of Science ®Google Scholar
• Van der Veen C., Buitendjik H., Lerk C. F. The effect of acidic excipients on the release of weakly basic drugs from the programmed release megaloporous system. Eur. J. Pharm. Biopharm. 1991; 37(4)238–242
   Web of Science ®Google Scholar
• Brazel C. S., Peppas N. A. Modeling of drug release from swellable polymers. Eur. J. Pharm. Biopharm. 2000; 49: 47–58
   PubMed Web of Science ®Google Scholar
• Ranga Rao K. V., Padmalatha Devi K., Buri P. Cellulose matrices for zero‐order release of soluble drugs. Drug Dev. Ind. Pharm. 1988; 14(15‐17)2299–2320
   Web of Science ®Google Scholar
• Bonny J. D., Leunberger H. Matrix type controlled release systems. II. Percolation effects in non‐swellable matrices. Pharm. Acta Helv. 1993; 68: 25–33
   Google Scholar
• Bauer K. H., Lehman K., Osterwald H. P., Rothgang G. Überzogene Arzneiformen. Wiessenschaftliche Verlagsgesellschaft, Stuttgart 1988; 210
   Google Scholar
• Ford J. L., Rubinstein M. H., Mac Caul F., Hogan J. E., Edgar P. J. Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropylmethylcellulose matrix tablets. Int. J. Pharm. 1993; 40: 223–234, 1987
   Google Scholar
• Juárez H., Rico G., Villafuerte L. Influence of admixed carboxymethylcellulose on release of 4‐aminopyridine from hydroxypropyl methylcellulose matrix tablets. Int. J. Pharm. 2001; 216: 115–125
   PubMed Web of Science ®Google Scholar
• Martínez‐González I., Villafuerte‐Robles L. Effect of varying the restriction degree of 4‐aminopyridine release from HPMC matrices on the mechanism controlling the process. Int. J. Pharm. 2003; 257: 253–264
   PubMed Web of Science ®Google Scholar
• Sung K. C., Nixon P. R., Skoug J. W., Ju T. R., Gao P., Topp E. M., Patel M. V. Effect of formulation variables on drug and polymer release from HPMC—based matrix tablets. Int. J. Pharm. 1996; 142: 53–60
   Web of Science ®Google Scholar